These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36792257)

  • 1. Guideline-Directed Medical Therapy and Long-Term Mortality and Amputation Outcomes in Patients Undergoing Peripheral Vascular Interventions.
    Smolderen KG; Romain G; Provance JB; Scierka LE; Mao J; Goodney PP; Henke PK; Sedrakyan A; Mena-Hurtado C
    JACC Cardiovasc Interv; 2023 Feb; 16(3):332-343. PubMed ID: 36792257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in guideline-directed medical therapy across sites and operators and long-term mortality and amputation outcomes risk in patients undergoing peripheral vascular interventions.
    Smolderen KG; Romain G; Cleman J; Scierka L; Mena-Hurtado C
    Am Heart J; 2024 Apr; 270():75-85. PubMed ID: 38307364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guideline-Directed Medical Therapy in Patients with Chronic Kidney Disease Undergoing Peripheral Vascular Intervention.
    Jelani QU; Llanos-Chea F; Bogra P; Trejo-Paredes C; Huang J; Provance JB; Turner J; Anantha-Narayanan M; Sheikh AB; Smolderen KG; Mena-Hurtado C
    Am J Nephrol; 2021; 52(10-11):845-853. PubMed ID: 34706363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease.
    Altin SE; Castro-Dominguez YS; Kennedy KF; Orion KC; Lanksy AJ; Abbott JD; Aronow HD
    JACC Cardiovasc Interv; 2020 Dec; 13(24):2911-2918. PubMed ID: 33357529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.
    Schneider PM; Pellegrini CN; Wang Y; Fein AS; Reynolds MR; Curtis JP; Masoudi FA; Varosy PD
    Am J Cardiol; 2014 Jun; 113(12):2052-6. PubMed ID: 24793671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction.
    Sumarsono A; Xie L; Keshvani N; Zhang C; Patel L; Alonso WW; Thibodeau JT; Fonarow GC; Van Spall HGC; Messiah SE; Pandey A
    Circulation; 2024 Feb; 149(7):510-520. PubMed ID: 38258605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Ge Z; Baber U; Claessen BE; Farhan S; Chandrasekhar J; Li SX; Sartori S; Kini AS; Rao SV; Weiss S; Henry TD; Vogel B; Sorrentino S; Faggioni M; Kapadia S; Muhlestein B; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Catheter Cardiovasc Interv; 2019 Feb; 93(3):E112-E119. PubMed ID: 30351514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
    Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
    Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Failure Hospitalization and Guideline-Directed Prescribing Patterns Among Heart Failure With Reduced Ejection Fraction Patients.
    Srivastava PK; DeVore AD; Hellkamp AS; Thomas L; Albert NM; Butler J; Patterson JH; Spertus JA; Williams FB; Duffy CI; Hernandez AF; Fonarow GC
    JACC Heart Fail; 2021 Jan; 9(1):28-38. PubMed ID: 33309579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.
    Wolfe NK; Mitchell JD; Brown DL
    Eur Heart J Qual Care Clin Outcomes; 2021 Jul; 7(4):416-421. PubMed ID: 32324852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of lower extremity bypass and peripheral vascular intervention for chronic limb-threatening ischemia in the Medicare-linked Vascular Quality Initiative.
    Cleman J; Romain G; Grubman S; Guzman RJ; Smolderen KG; Mena-Hurtado C
    J Vasc Surg; 2023 Sep; 78(3):745-753.e6. PubMed ID: 37207790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry.
    Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC
    J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction.
    Lee YC; Lin JK; Ko D; Cheng S; Patorno E; Glynn RJ; Tsacogianis T; Kim DH
    J Am Geriatr Soc; 2023 Oct; 71(10):3110-3121. PubMed ID: 37345734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
    Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
    JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry.
    Lainščak M; Milinković I; Polovina M; Crespo-Leiro MG; Lund LH; Anker SD; Laroche C; Ferrari R; Coats AJS; McDonagh T; Filippatos G; Maggioni AP; Piepoli MF; Rosano GMC; Ruschitzka F; Simić D; Ašanin M; Eicher JC; Yilmaz MB; Seferović PM;
    Eur J Heart Fail; 2020 Jan; 22(1):92-102. PubMed ID: 31863522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adherence to guideline-directed therapy on risk of death in HF patients across an ejection fraction spectrum.
    Chen X; Kang Y; Dahlström U; Fu M
    ESC Heart Fail; 2023 Dec; 10(6):3656-3666. PubMed ID: 37803813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation.
    Roth GA; Poole JE; Zaha R; Zhou W; Skinner J; Morden NE
    J Am Coll Cardiol; 2016 Mar; 67(9):1062-1069. PubMed ID: 26940927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Pharmacotherapy and Long-Term Outcomes in Patients With Ischaemic Heart Disease and Comorbid Left Ventricular Dysfunction.
    Dagan M; Dinh DT; Stehli J; Nan Tie E; Brennan A; Ajani AE; Clark DJ; Freeman M; Reid CM; Hiew C; Oqueli E; Kaye DM; Duffy SJ;
    Heart Lung Circ; 2023 Dec; 32(12):1457-1464. PubMed ID: 37945426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.